Rezultati pretraživanja
  1. BREAKING NEWS: American rises for the first time in four years due to improvements in mortality rates and decline in death from opioid overdose.

  2. 4. velj
  3. A study found that the implementation of into clinical can provide accurate decision rules for the management of suspicious breast masses.

  4. The first cost-effectiveness analysis of CAR-T tisagenlecleucel compared with current standard care for pediatric patients with acute lymphoblastic leukemia (ALL) using a constructed population-based control arm.

  5. When great minds come together...Watch SOPHiA GENETICS co-founder discussing AI in Health during a Fireside chat with Illumina CMO at

  6. The next generation of -based methods will complement current methods, providing an insight into health and disease mechanisms.

  7. Using checkpoint blockade therapies in the neoadjuvant setting presents a potential solution for de novo or acquired resistance in the adjuvant setting.

  8. Molecular profile that includes data about the microbiome and genome, information about metabolites and proteins, and physiological measurements could reduce drug development cost and time.

  9. 31. sij

    Thanks to , Noam Shomron and the participants of the NGS Workflows For Clinical Diagnostics Applications panel for a great discussion last week. Topics included simplifying genomic testing for broader and more standardized applications. Let's keep the discussion going!

  10. 31. sij

    Catching Europe first, broadcasting from my spaceship in San Francisco, California - here's the 3min video we premiered at last week.

  11. Study of rare variants in the exomes of more than 70,000 individuals. Justin Kao led a panel on scalable return of genomics, at the PMWC 2020 Silicon Valley.

  12. 29. sij

    RT : The match of & may not seem intuitive, but there is more synergy in their engagement than meets the eye

  13. algorithms must show efficacy in robust clinical trials and in the real world to move into the next phase of clinical implementation. Dr. led a panel discussing those issues on Friday at .

  14. 29. sij

    Last week, Biological Dynamics CEO Raj Krishnan presented at , providing insights on the company’s novel lab-on-a-chip platform, Verita, that offers simplified workflow for isolation of blood-based circulating nanoparticles.

  15. 29. sij

    My favorite analyses from last week.

  16. 29. sij
  17. 28. sij

    It's great to connect with various experts at . We all want better and personalized care to predict and prevent serious diseases in Women's Health.

  18. 28. sij
    Odgovor korisnicima

    It was a great talk by

  19. 28. sij

    Thank you to everyone who attended and participated in our dedicated Patient Track at last week! We believe in keeping patients' needs at the center of conversations about oncology, and we're thrilled to have heard so many valuable perspectives.

  20. . shares his insights on one of the many critical topics covered at : how cancer patients get the clinical care they need. Check out Dr. Markman’s article in as he continues the conversation on patient advocacy:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.